UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Economic Burden of Schizophrenia in the United States in 2013

The journal of clinical psychiatry, 2016-06, Vol.77 (6), p.764-771

2016

Volltextzugriff (PDF)

Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course

International psychogeriatrics, 2019-09, Vol.31 (9), p.1305-1318

2019

Volltextzugriff (PDF)

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study

International journal of nephrology and renovascular disease, 2021, Vol.14, p.105-115

2021

Volltextzugriff (PDF)

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis

International journal of nephrology and renovascular disease, 2021-01, Vol.14, p.133-142

2021

Volltextzugriff (PDF)

Institutionalization risk and costs associated with agitation in Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.851-861

2019

Volltextzugriff (PDF)

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia

International journal of geriatric psychiatry, 2019-03, Vol.34 (3), p.420-431

2019

Volltextzugriff (PDF)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System

Journal of Alzheimer's disease, 2021-01, Vol.83 (1), p.89-101

2021

Volltextzugriff (PDF)

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

PharmacoEconomics, 2019-04, Vol.37 (4), p.597-608

2019

Volltextzugriff (PDF)

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis

BMC neurology, 2019-02, Vol.19 (1), p.33-33, Article 33

2019

Volltextzugriff (PDF)

The societal economic burden of autosomal dominant polycystic kidney disease in the United States

BMC health services research, 2020-02, Vol.20 (1), p.126-126, Article 126

2020

Volltextzugriff (PDF)

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review

Journal of Alzheimer's disease, 2020-01, Vol.77 (3), p.1181-1194

2020

Volltextzugriff (PDF)

The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study

Journal of medical Internet research, 2019-06, Vol.21 (6), p.e13360-e13360

2019

Volltextzugriff (PDF)

Cost-Effectiveness of Brexpiprazole Adjunctive Treatment for Major Depressive Disorder

Journal of affective disorders, 2017-01, Vol.207, p.54-62

2017

Volltextzugriff (PDF)

Severity of memory impairment in the elderly: Association with health care resource use and functional limitations in the United States

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2017, Vol.8 (1), p.51-59

2017

Volltextzugriff (PDF)

Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States

Current medical research and opinion, 2021-07, Vol.37 (7), p.1155-1162

2021

Volltextzugriff (PDF)

P1‐295: BEHAVIORAL SYMPTOMS AND DISTURBANCES IN DEMENTIA: A HIGHLY PREVALENT CONDITION

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_7), p.P356-P356

2019

Volltextzugriff (PDF)

BEHAVIORAL SYMPTOMS AND DISTURBANCES IN DEMENTIA: A HIGHLY PREVALENT CONDITION

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P356-P356

2019

Volltextzugriff (PDF)

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis

International journal of nephrology and renovascular disease, 2021-05, Vol.14, p.133

2021

Volltextzugriff (PDF)

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based SurveyPlain-Language Summary

Kidney medicine, 2022-04, Vol.4 (4), p.100439

2022

Volltextzugriff (PDF)

P3‐411: The Role of Dependence in Alzheimer's Disease Dementia: A Systematic Literature Review

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_20), p.P1009-P1009

2016

Volltextzugriff (PDF)

THE ROLE OF DEPENDENCE IN ALZHEIMER’S DISEASE DEMENTIA: A SYSTEMATIC LITERATURE REVIEW

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1009-P1009

2016

Volltextzugriff (PDF)

FAMILY AND CAREGIVER SPILLOVER EFFECTS IN ALZHEIMER’S DISEASE COST-EFFECTIVENESS ANALYSES

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1565-P1566

2017

Volltextzugriff (PDF)

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey

Kidney medicine, 2022-04, Vol.4 (4), p.100439-100439, Article 100439

2022

Volltextzugriff (PDF)

A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients

Neurology and therapy, 2017-06, Vol.6 (1), p.131-144

2017

Volltextzugriff (PDF)

Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases

Innovations in clinical neuroscience, 2016-08, Vol.13 (7-8), p.17-25

2016

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Economic Burden of Schizophrenia in the United States in 2013

Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis

Institutionalization risk and costs associated with agitation in Alzheimer's disease

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis

The societal economic burden of autosomal dominant polycystic kidney disease in the United States

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review

The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study

Cost-Effectiveness of Brexpiprazole Adjunctive Treatment for Major Depressive Disorder

Severity of memory impairment in the elderly: Association with health care resource use and functional limitations in the United States

Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States

P1‐295: BEHAVIORAL SYMPTOMS AND DISTURBANCES IN DEMENTIA: A HIGHLY PREVALENT CONDITION

BEHAVIORAL SYMPTOMS AND DISTURBANCES IN DEMENTIA: A HIGHLY PREVALENT CONDITION

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based SurveyPlain-Language Summary

P3‐411: The Role of Dependence in Alzheimer's Disease Dementia: A Systematic Literature Review

THE ROLE OF DEPENDENCE IN ALZHEIMER’S DISEASE DEMENTIA: A SYSTEMATIC LITERATURE REVIEW

FAMILY AND CAREGIVER SPILLOVER EFFECTS IN ALZHEIMER’S DISEASE COST-EFFECTIVENESS ANALYSES

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey

A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients

Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases

Suchergebnisse filtern